Welcome to the PHARMAGEST Group’s Finance space.

This space has been designed to tell you about the Group’s results, as well as about all the practical details related to holding shares in PHARMAGEST INTERACTIVE. If you don’t find the answers to your questions, don’t hesitate to contact us.

PHARMAGEST INTERACTIVE

Listed on Euronext Paris™ – Sub-fund A
Indices: MSCI GLOBAL SMALL CAP – GAÏA Index 2020 – CAC® SMALL and CAC® All-Tradable by inclusion
Included under the European Rising Tech Label
Eligible for the Deferred Settlement Service (SRD) and for France’s Equity Savings Plan intended to finance SMEs (PEA-PME)
ISIN: FR 0012882389 – Reuters: PHA.PA – Bloomberg: – PMGI FP

NEWS

Extraordinary General Meeting on 6 May 2022 :

Pharmagest Group will change its name to EQUASENS Group

Results of the votes of the resolutions submitted to the Extraordinary General Meeting of 6 May 2022

PRESS RELEASES

2021 ANNUAL RESULTS – NET PROFIT: €41.15m, up 25.97%

2021 REVENUE: €193.07m, up 12.41%

PRESENTATION SFAF – 2021 ANNUAL RESULTS (Monday 28.03.2022)

FINANCIAL ANALYSIS